A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Lila Sciences has secured $200 million in seed funding from Flagship Pioneering, which incubated the company, and General ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

The region has more than 10M SF of planned lab development that hasn't broken ground as the market remains slow.

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.

Boston Scientific (BSX) ended the recent trading session at $104.71, demonstrating a +1.06% swing from the preceding day's closing price. This change lagged the S&P 500's 1.12% gain on the day.

Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), The Progressive Corp. (PGR) and Boston Scientific Corp. (BSX), as well as ...

The United States has historically made substantial scientific and monetary contributions to the IPCC. US scientists publish research that informs the assessment and run computer simulations of ...

TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration. The ...

TUESDAY, Feb. 25, 2025 (HealthDay News) -- Boston Scientific has issued a recall of Accolade pacemaker devices, according to a safety communication from the U.S. Food and Drug Administration.